课题基金 / 基金详情

Patient consequences following tuberculosis (TB) therapy: identifying those at risk of post-treatment relapse, reinfection, increased morbidity, and mortality in a high TB burden setting

Patient consequences following tuberculosis (TB) therapy: identifying those at risk of post-treatment relapse, reinfection, increased morbidity, and mortality in a high TB burden setting
结核病 (TB) 治疗后的患者后果：识别高结核病负担环境中存在治疗后复发、再感染、发病率和死亡率增加风险的患者
批准号：
457047
负责人：
Khan Uzma
金额：
$7.65万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=457047&lang=en
关键词：
Drug-Resistant Tuberculosis Global Health Mortality Pakistan Post-Tb Lung Disease Post-Treatment Outcomes Quality-Of-Care Reinfection Relapse Vulnerable Groups

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Tuberculosis (TB) is an airborne infectious disease affecting 10 million people worldwide. In Canada, it affects indigenous communities disproportionately, with TB rates in Inuit communities being 300 times higher than Canadian-born non-Indigenous people.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金